New technique to study the genetics of breast cancer

Nov 11, 2008

A new technique to study genetic changes that can lead to breast cancer could be one step closer.

The University of Nottingham has received £15,000 from the charity Breast Cancer Campaign to fill in one of the research gaps identified by the country's top breast cancer experts in a recent study carried out by the charity. The aim is to identify the many undiscovered genes thought to be involved in the early stages of breast cancer.

The grant awarded to Ian Ellis, Professor of Cancer Pathology, is part of £2.3 million awarded to 20 projects around the UK. Professor Ellis said: "Thanks to funding from Breast Cancer Campaign I hope to develop a technique which would allow the genetic information of many thousands of breast samples to be studied which would be of huge importance in understanding the genetic changes that occur in early breast cancer."

It is known that breast cancer can develop when the genes in breast cells change and stop working properly. Inherited defects in genes account for around five to 10 per cent of all breast cancers but all forms of breast cancer have acquired gene defects during their initial stages of development and many of these genes are yet to be discovered. These defective genes can lead to physical changes in the breast cancer cell resulting in breast cancer.

The earliest physical sign of a normal breast cell developing into one common type of breast cancer is the presence of a flat atypical epithelial (FEA) cell. Professor Ellis will study the genes in the FEA cells to identify which ones are involved in the very earliest stages of breast cancer.

Pamela Goldberg, Chief Executive, Breast Cancer Campaign, said, "Every year breast cancer kills 12,500 women in the UK. It is therefore vital that we identify new genes involved in breast cancer development so that women who inherit these faulty genes and are therefore at higher risk of breast cancer, can be monitored at an early stage."

Source: University of Nottingham

Explore further: Cancer diagnoses will rise as population ages

Related Stories

New target for anticancer drugs—RNA

Apr 06, 2015

Most of today's anticancer drugs target the DNA or proteins in tumor cells, but a new discovery by University of California, Berkeley, scientists unveils a whole new set of potential targets: the RNA intermediaries ...

Small RNA plays big role suppressing cancer

Apr 02, 2015

The micro RNA miR-22 has long been known for its ability to suppress cancer. However, questions remain about how it achieves this feat. For example, which molecules are regulating miR-22, and which are miR22 ...

Recommended for you

Cancer diagnoses will rise as population ages

2 hours ago

Cancer is a leading cause of death in Virginia and researchers at the University of Virginia's Weldon Cooper Center for Public Service project that the rate of growth in new cancer cases will far outpace ...

Omega-3 hope for cancer patients

3 hours ago

The chemistry involved in designing drugs with the potential to treat cancer is complex and finicky. The placement of a single atom can be the difference between a cancer killer and a useless bystander. And ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.